DD297326A5 - Stabilisierung von perfluorcarbonemulsionen und als emulsionsstabilisierende zusaetze verwendbare perfluorierte heterocyclische verbindungen - Google Patents

Stabilisierung von perfluorcarbonemulsionen und als emulsionsstabilisierende zusaetze verwendbare perfluorierte heterocyclische verbindungen Download PDF

Info

Publication number
DD297326A5
DD297326A5 DD90343688A DD34368890A DD297326A5 DD 297326 A5 DD297326 A5 DD 297326A5 DD 90343688 A DD90343688 A DD 90343688A DD 34368890 A DD34368890 A DD 34368890A DD 297326 A5 DD297326 A5 DD 297326A5
Authority
DD
German Democratic Republic
Prior art keywords
group
gruppe
perfluorocarbons
compounds
mixtures
Prior art date
Application number
DD90343688A
Other languages
German (de)
English (en)
Inventor
Hasso Meinert
Juergen Mader
Rudolf Fackler
Peter Reuter
Wolfgang Roehlke
Monika Gennies
Joachim Baer
Original Assignee
����`��@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ����`��@���k�� filed Critical ����`��@���k��
Publication of DD297326A5 publication Critical patent/DD297326A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/38—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00—Electrolytic production of organic compounds
    • C25B3/01—Products
    • C25B3/05—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00—Electrolytic production of organic compounds
    • C25B3/01—Products
    • C25B3/07—Oxygen containing compounds
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00—Electrolytic production of organic compounds
    • C25B3/01—Products
    • C25B3/09—Nitrogen containing compounds
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00—Electrolytic production of organic compounds
    • C25B3/01—Products
    • C25B3/11—Halogen containing compounds
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00—Electrolytic production of organic compounds
    • C25B3/20—Processes
    • C25B3/27—Halogenation
    • C25B3/28—Fluorination

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Gas Separation By Absorption (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD90343688A 1989-08-30 1990-08-28 Stabilisierung von perfluorcarbonemulsionen und als emulsionsstabilisierende zusaetze verwendbare perfluorierte heterocyclische verbindungen DD297326A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3928692 1989-08-30

Publications (1)

Publication Number Publication Date
DD297326A5 true DD297326A5 (de) 1992-01-09

Family

ID=6388191

Family Applications (2)

Application Number Title Priority Date Filing Date
DD90343688A DD297326A5 (de) 1989-08-30 1990-08-28 Stabilisierung von perfluorcarbonemulsionen und als emulsionsstabilisierende zusaetze verwendbare perfluorierte heterocyclische verbindungen
DD90343686A DD297458A5 (de) 1989-08-30 1990-08-28 Verfahren zur herstellung perfluorierter heterocyclischer verbindungen und nach diesem verfahren hergestellte verbindungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD90343686A DD297458A5 (de) 1989-08-30 1990-08-28 Verfahren zur herstellung perfluorierter heterocyclischer verbindungen und nach diesem verfahren hergestellte verbindungen

Country Status (9)

Country Link
US (1) US5260496A (ja)
EP (1) EP0489773B1 (ja)
JP (1) JP2918063B2 (ja)
AT (1) ATE96139T1 (ja)
DD (2) DD297326A5 (ja)
DE (2) DE59003169D1 (ja)
DK (1) DK0489773T3 (ja)
ES (1) ES2045944T3 (ja)
WO (1) WO1991003442A2 (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409688A (en) * 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
HU218018B (hu) * 1991-09-17 2000-05-28 Sonus Pharmaceuticals Inc. Gázos ultrahang-kontrasztanyag és eljárás ultrahang kontrasztanyaghoz megfelelő gázok kiválasztására
MX9205298A (es) * 1991-09-17 1993-05-01 Steven Carl Quay Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
US6723303B1 (en) 1991-09-17 2004-04-20 Amersham Health, As Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane
HUT72323A (en) * 1993-01-25 1996-04-29 Sonus Pharma Inc Phase shift colloids as ultrasound contrast agents
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Phase shift colloids as ultrasound contrast agents
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
CH686134A5 (de) * 1994-05-10 1996-01-15 Lonza Ag Gampel Wallis Geschof Tertiores Diamin, Verwendung als Katalysator und Verfahren zur Herstellung von tertioren Diaminen.
US5611344A (en) * 1996-03-05 1997-03-18 Acusphere, Inc. Microencapsulated fluorinated gases for use as imaging agents
US5837221A (en) * 1996-07-29 1998-11-17 Acusphere, Inc. Polymer-lipid microencapsulated gases for use as imaging agents
US6375912B1 (en) * 1999-08-16 2002-04-23 Agere Systems Guardian Corp. Electrochemical abatement of perfluorinated compounds
US8012457B2 (en) 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
JP5181869B2 (ja) * 2008-06-27 2013-04-10 東ソー株式会社 Ｐｆｃ吸着剤及びそれを用いたｐｆｃ除害方法
US8075742B2 (en) 2009-02-27 2011-12-13 Midwest Refrigerants, Llc Apparatus and process for the separation and purification of ideal and non-ideal refrigerant mixtures
US8128902B2 (en) * 2011-04-12 2012-03-06 Midwest Refrigerants, Llc Method for the synthesis of anhydrous hydrogen halide and anhydrous carbon dioxide
US8043574B1 (en) 2011-04-12 2011-10-25 Midwest Refrigerants, Llc Apparatus for the synthesis of anhydrous hydrogen halide and anhydrous carbon dioxide
US8834830B2 (en) 2012-09-07 2014-09-16 Midwest Inorganics LLC Method for the preparation of anhydrous hydrogen halides, inorganic substances and/or inorganic hydrides by using as reactants inorganic halides and reducing agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL239962A (ja) * 1958-06-09
GB1052555A (ja) * 1963-05-31
DE1206424B (de) * 1964-05-27 1965-12-09 Hoechst Ag Verfahren zum Abtrennen von Difluormethan aus Gemischen von Difluormethan und Tetrafluoraethylen
DD256692A1 (de) * 1985-12-20 1988-05-18 Akad Wissenschaften Ddr Verfahren zur sorption von fluorierten kohlenstoffverbindungen
US4906796A (en) * 1989-03-08 1990-03-06 Allied Signal Inc. Process for purifying 1,1,1,2-tetrafluoroethane

Also Published As

Publication number Publication date
DE59003169D1 (de) 1993-11-25
EP0489773B1 (de) 1993-10-20
WO1991003442A3 (de) 1991-05-02
DE4027143A1 (de) 1991-03-07
US5260496A (en) 1993-11-09
EP0489773A1 (de) 1992-06-17
ATE96139T1 (de) 1993-11-15
JPH05500046A (ja) 1993-01-14
JP2918063B2 (ja) 1999-07-12
ES2045944T3 (es) 1994-01-16
DK0489773T3 (da) 1993-11-29
WO1991003442A2 (de) 1991-03-21
DD297458A5 (de) 1992-01-09

Similar Documents

Publication Publication Date Title
DD297458A5 (de) Verfahren zur herstellung perfluorierter heterocyclischer verbindungen und nach diesem verfahren hergestellte verbindungen
DE3877595T2 (de) Haltbare waesserige emulsionen aus fluorkohlenwasserstoffen.
DE4127442C2 (de) Wäßrige Dispersion Fluorcarbon enthaltender Phospholipid-Vesikel und ein Verfahren zu ihrer Herstellung
DE69000346T2 (de) Fluorierte mikroemulsion als sauerstoff-traeger.
EP0415263B1 (de) Stabilisierung von Perfluorcarbonemulsionen und als emulsionsstabilisierende Zusätze verwendbare perfluorierte heterocyclische Verbindungen
DE69726408T2 (de) Verfahren zur herstellung von platinverbindungen
DE3390172T1 (de) Perfluorkohlenstoff-Emulsionen, deren Herstellung und deren Verwendung in der Therapie
EP0415264B1 (de) Verfahren zur Herstellung perfluorierter heterocyclischer Verbindungen und nach diesem Verfahren hergestellte Verbindungen
EP0493677A2 (de) Behandlungsflüssigkeit zum Wiederanlagen (Entfalten) abgelöster Netzhaut an die Aderhaut des Auges
DE3303116C2 (ja)
CH658051A5 (de) Perfluorocycloamine und praeparat aus einer perfluorocycloamin-emulsion.
DE2807643A1 (de) Neue derivate des 20,21-dinoreburnamenins, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE2555408C2 (ja)
EP2142169B1 (de) Wässrige pharmazeutische zubereitung
DE3041368A1 (de) Loesungsmittelgemische zur herstellung von parenteralverabreichbaren stabilen injektionsloesungen und deren verwendung
CH656533A5 (de) Therapeutisches praeparat enthaltend hydrierte ergotalkaloide und niedermolekulares heparin.
AT367021B (de) Verfahren zur herstellung neuer indene
DE2152001C3 (de) 3-Piperidino- und 3-Morpholinopropylbenzoate und deren Salze, Verfahren zur Herstellung derselben sowie solche Verbindungen enthaltende Arzneimittel
EP4580680A1 (de) Lecithin-modifizierte nanoskalierte sauerstoffträger (lenox)
AT333750B (de) Verfahren zur herstellung von neuen 2-(aminophenylimino)-3-aza-1-thia-cycloalkanderivaten und ihren salzen
DE202023104202U1 (de) Eine neue antimykotische Zusammensetzung und ihre Synthese
AT304506B (de) Verfahren zur Herstellung neuer Anthracenverbindungen
DD280130A1 (de) Verfahren zur herstellung perfluorierter n-cyclohexylmethylderivate cyclischer amine
EP0108248A2 (de) Lösungsvermittlerfreie, wässrige Nitroglycerinlösung
DD275079A1 (de) Verfahren zur herstellung perfluorierter dicyclischer amine

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee